Study Of Use Of Pashanbhedadi Ghanvati In The Treatment Of Enlargement Of Prostate.

Phase 2

• Conditions: Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

• Registration Number: CTRI/2020/11/029083
• Lead Sponsor: Preeti Bhalke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients having prostate size 30 to 100 gram

Patients having post void residual volume 50 to 200 ml

Patients willing to participate in study

Patients having mild 1 to 7 moderate 8 to 19 international prostate symptom score

Patients with severe 20 to 35 international prostate symptom score with no other consequences of benign prostate Hyperplasia and reluctant for surgery

Exclusion Criteria

Patients of malignant prostatic enlargement or prostatitis or uremia septicemia or renal failure

Patients having other urological pathologies like nephrotic syndrome or glomerulo nephritis or chronic kidney diseases etc

Increased serum creatinine and blood urea

Patients having HIV or HBsAg or major systemic disorders like uncontrolled HTN or DM or PTB etc

Patients participating in other clinical trials

Patients having hematuria

Patients with acute urine retention which needs surgical intervention

Patients currently using any other form of medicle therapy for benign prostate hyperplasia

Study & Design

• Study Type: Interventional
• Study Design: Not specified